Currently, polycationic nanoparticles (polycation) as nonviral vectors are promising to overcome the defects of
traditional viral vectors. This review focuses on the recent progress and challenges to improve the transfection efficacy
and circulation time of polyplexes (complexes between polycation and pDNA or oligonucleotides such as siRNA ) in
vivo.